![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Kudlacz E.M.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.7, Iss.7, 1998-07, pp. : 1055-1062
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bisindoles as tachykinin receptor antagonists
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A role of tachykinin NK 2 receptor antagonists in the treatment of IBS?
By Lecci A.
Trends in Pharmacological Sciences, Vol. 22, Iss. 11, 2001-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tachykinin receptor antagonists for asthma and COPD
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 7, 2001-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)